Insider Trading Summary for Onyx Pharmaceuticals Inc. (ONXX): Three Months

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
24-Apr-13 4:11 PM View:	23-Apr-13 Market Option Sale (Planned) ($506.40K)	Grillo Lopez Antonio J Director		Onyx Pharmaceuticals Inc. - ONXX	47% 4.5K to 6.6K	0	($6.97M) (1626%)	--	$91.36 - $101.28	Show Txns Hide Txns

01-Apr-13 7:37 PM View:	28-Mar-13 Grant 0	Wierenga Wendall D Director		Onyx Pharmaceuticals Inc. - ONXX	23% 9.08K to 11.18K	0	0	--	--	Show Txns Hide Txns

08-May-13 8:43 PM View:	08-May-13 Market Option Sale (Planned) ($95.00K)	Goddard Paul Director		Onyx Pharmaceuticals Inc. - ONXX	16% 12.79K to 14.89K	0	($1.13M) (102%)	--	$74.35 - $95.00	Show Txns Hide Txns

11-Apr-13 9:02 PM View:	11-Apr-13 Market Option Sale (Planned) ($960.00K)	Lundberg Magnus Director		Onyx Pharmaceuticals Inc. - ONXX	17% 12.12K to 14.22K	0	($2.32M) (206%)	--	$88.00 - $96.00	Show Txns Hide Txns

23-May-13 4:49 PM View:	21-May-13 Gift 0	Wiggans Thomas G Director		Onyx Pharmaceuticals Inc. - ONXX	1% 8.06K to 8.12K	0	($1.09M) (157%)	--	$77.20 - $91.01	Show Txns Hide Txns

01-Apr-13 7:40 PM View:	28-Mar-13 Grant 0	Lyle Corinne H Director		Onyx Pharmaceuticals Inc. - ONXX	28% 7.5K to 9.6K	0	0	--	--	Show Txns Hide Txns

08-May-13 8:44 PM View:	07-May-13 Market Option Sale (Planned) ($797.50K)	Foster-Cheek Kaye I SVP, Global Human Resources		Onyx Pharmaceuticals Inc. - ONXX	6% 25.5K to 27.07K	0	($1.13M) (50%)	--	$86.15 - $89.84	Show Txns Hide Txns

01-Apr-13 7:38 PM View:	28-Mar-13 Grant 0	Ringo William R Director		Onyx Pharmaceuticals Inc. - ONXX	27% 7.74K to 9.84K	0	0	--	--	Show Txns Hide Txns

11-Apr-13 9:45 PM View:	10-Apr-13 Market Option Sale (Planned) ($945.07K)	Wood Julianna R VP, Public Affairs		Onyx Pharmaceuticals Inc. - ONXX	6% 18.42K to 19.57K	0	($1.31M) (77%)	--	$85.65 - $95.00	Show Txns Hide Txns

15-May-13 7:43 PM View:	13-May-13 Market Option Sale (Planned) ($809.61K)	Torley Helen EVP, Chief Commercial Officer		Onyx Pharmaceuticals Inc. - ONXX	21% 39.51K to 47.65K	0	($849.75K) (22%)	--	$86.14 - $98.13	Show Txns Hide Txns

08-May-13 8:43 PM View:	07-May-13 Market Option Sale (Planned) ($364.48K)	Shema Suzanne M EVP, GC and Corp. Secretary		Onyx Pharmaceuticals Inc. - ONXX	2% 33.83K to 34.62K	0	($1.51M) (51%)	--	$79.72 - $89.97	Show Txns Hide Txns

16-May-13 8:39 PM View:	14-May-13 Market Sale ($403.97K)	Lasowski Juergen EVP, Corp. Dev & Strategy		Onyx Pharmaceuticals Inc. - ONXX	1% 31.82K to 32.08K	0	($632.32K) (21%)	--	$86.14 - $96.60	Show Txns Hide Txns

15-May-13 6:51 PM View:	13-May-13 Market Option Sale (Planned) ($1.01M)	Fust Matthew K EVP & Chief Financial Officer		Onyx Pharmaceuticals Inc. - ONXX	0% 50.2K to 50.2K	0	($2.63M) (61%)	--	$77.12 - $98.22	Show Txns Hide Txns

13-Mar-13 7:44 PM View:	11-Mar-13 Grant 0	Cagnoni Pablo J EVP, Global R&D and Tech Ops		Onyx Pharmaceuticals Inc. - ONXX	100% 0 to 16.26K	0	0	--	--	Show Txns Hide Txns

03-Apr-13 8:20 PM View:	03-Apr-13 Market Sale (Planned) ($363.02K)	Coles N Anthony Chairman & CEO Director		Onyx Pharmaceuticals Inc. - ONXX	21% 108.45K to 131.2K	0	($2.85M) (30%)	--	$86.14 - $90.00	Show Txns Hide Txns

Buy:	0	--
Sell:	($22.42M)	$74.35 - $101.28

Onyx Pharmaceuticals Inc. (ONXX)

Last Three Months

26-Feb-13 -- 25-May-13

Company Sentiment

Biotechnology

Drugs

Two Year Chart

26-May-11 -- 25-May-13

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades